Study details
Enrolling now
MDMA-assisted Therapy for Fibromyalgia
Spaulding Rehabilitation Hospital
NCT IDNCT06066853ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
20
Study length
about 12 months
Ages
21–65
Locations
1 site in MA
About this study
Researchers are testing if MDMA-assisted therapy can help people with fibromyalgia. The trial will involve two sessions of MDMA combined with neuroimaging and integrative therapy, along with baseline and follow-up imaging. The goal is to see how this treatment affects the patient-clinician relationship and brain activity in these patients.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take MDMA
PhaseEARLY_Phase 1
Routeoral
Primary goalChange in self-reported pain severity and pain interference (Brief Pain Inventory)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
oral
Endpoints
Primary: Change in self-reported pain severity and pain interference (Brief Pain Inventory)
Body systems
Musculoskeletal